SS Innovations completes $18.6M private placement; funds expansion, FDA review mid-2026

SS Innovations International, Inc.

Raised $18.6M gross via private placement of 5,774,839 shares at $3.00-$4.01 per share.
Insiders invested $5.2M: CEO ($2.0M), Vice Chairman Moll ($2.0M), Director Adams ($1.2M).
External investors, led by Manipal Global Health Services, invested $13.4M at $3.00/share.
Proceeds for working capital, global expansion, and preparation for US/EU market entry.
FDA 510(k) review for SSi Mantra system expected mid-2026; CE marking targeted in 2026.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.97

SS Innovations International, Inc. issued warrants to purchase 41,667 shares of our common stock of warrant to a FINRA member firm for exercise price of $3.45 per share.

Security: warrant
Shares: warrants to purchase 41,667 shares of our common stock
Purchaser: a FINRA member firm
Consideration: exercise price of $3.45 per share

Exact text from the filing

the Company will pay a FINRA member firm a cash commission of $175,000 (7% of the investment) and issue to such firm five-year warrants to purchase 41,667 shares of our common stock at an exercise price of $3.45 per share

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.98

SS Innovations International, Inc. issued 1,300,006 shares of common stock to Dr. Sudhir Srivastava, Dr. Frederic Moll, and Tim Adams for at an average price of $4.00 per share for a total of approximately $5.2 million.

Security: common stock
Shares: 1,300,006 shares
Purchaser: Dr. Sudhir Srivastava, Dr. Frederic Moll, and Tim Adams
Consideration: at an average price of $4.00 per share for a total of approximately $5.2 million

Exact text from the filing

an aggregate of 1,300,006 shares of common stock at an average price of $4.00 per share for a total of approximately $5.2 million, to Dr. Sudhir Srivastava, our Chairman and Chief Executive Officer (498,753 shares at $4.01 per share for a total of $2.0 million), Dr. Frederic Moll, our Vice Chairman (501,253 shares at $3.99 per share for a total of $2.0 million), and Tim Adams, a director (300,000 shares at $3.99 per share for a total of $1.2 million)

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.98

SS Innovations International, Inc. issued 4,474,833 shares of common stock of common stock to existing and new investors, led by Manipal Global Health Services for at $3.00 per share for a total of approximately $13.4 million.

Security: common stock
Shares: 4,474,833 shares of common stock
Purchaser: existing and new investors, led by Manipal Global Health Services
Consideration: at $3.00 per share for a total of approximately $13.4 million

Exact text from the filing

an aggregate of 4,474,833 shares of common stock at $3.00 per share for a total of approximately $13.4 million, to existing and new investors, led by Manipal Global Health Services

View on SEC.gov

172 equity issuances filed in the last 30 days. Browse all equity issuances →

SS Innovations International, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-024938

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.